Download PDF
Facial Plast Surg 2019; 35(03): 274-277
DOI: 10.1055/s-0039-1688943
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Overview of Kybella (Deoxycholic Acid Injection) as a Fat Resorption Product for Submental Fat

Michael Liu
1   Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California
,
Cameron Chesnut
2   University of Washington School of Medicine, Spokane, Washington
3   Chesnut MD Cosmetic Surgery Fellowship at Dermatology Specialists of Spokane, Spokane, Washington
,
Gary Lask
1   Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
12 June 2019 (online)

Also available at
    Permissions and Reprints

Abstract

There has been an increasing interest in addressing the issue of submental fat (SMF) when it comes to cosmetic medicine. With the rise of social media, video calls, and the now almost omnipresent accessibility of cameras, there is perhaps now more than ever an emphasis on the facial image. Although invasive procedures such as liposuction and neck lift still play a significant role in reducing SMF, the trend toward minimally invasive methods has finally given rise to a single Food and Drug Administration-approved injectable that is both safe and effective: ATX-101, also known as Kybella in the United States.

Keywords

Kybella - submental fat - deoxycholic acid